Long-term activation of astrocytic hM3Dq in the hippocampal CA1 region induces LCN2 release, neuroinflammation, and cognitive impairments. by Jae-Hong Kim (124622)

Presentation_1_Risk of severe COVID-19 infection in persons with diabetes during the first and second waves in Denmark: A nationwide cohort study.pdf by Jacob V. Stidsen (8560017)

“…However, when mortality was restricted to the hospitalized population, the crude mortality fell from 26.8% to 19.6% in persons with diabetes, while only a minor decrease was seen in persons without diabetes (from 16.7% to 15.5%).…”

Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized, Double-Blind Placebo-Controlled Clinical Trial by Christa Kasang (345821)

“…Secondary endpoints: Prednisolone-treatment decreased immune activation (sCD14, suPAR, CD38/HLA-DR/CD8+) and increased CD4-counts (+77.42 ± 5.70 cells/μl compared to -37.42 ± 10.77 cells/μl under placebo, p < 0.0001). …”

Summary of trend results based on Mann-Kendall test and Sen’s slope estimator for the 34 weather stations (arranged according to administrative division, in bold) for the wet seaso... by Mohammed Mainuddin (8723352)

GSK3β is negatively regulated by OPTN during myogenesis. by Xiao Chen Shi (8611887)

Effects of a Family-Based Childhood Obesity Treatment Program on Parental Weight Status by Cæcilie Trier (700327)

“…Both the mothers and fathers lost weight during their child’s treatment with a mean decrease in BMI in the mothers of 0.5 (95% CI: 0.2–0.8, <i>p</i> = 0.0006) and in the fathers of 0.4 (95% CI: 0.2–0.6, <i>p</i> = 0.0007). …”

Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes by Shiliang Li (298790)

“…The long-term antidiabetic efficacies of <b>5</b> (10 mg/kg, qw) were better than those of the once-weekly trelagliptin and omarigliptin, especially in decreasing the hemoglobin A1c level.…”

Gene Ontology network analysis of differentially-enriched Vpu-proximal protein subsets. by Charlotte A. Stoneham (10819125)

Set1 complex Set1 and Swd1 subunits associate in meiosis with highly transcribed genes, but not with chromosome axis sites. by Céline Adam (320770)

Uncertainty analyses of unadjusted data from Scenarios 1–3: each dot represents one simulation. by Jie Lou (535356)

Heat map and k-means clustering of proteins (384) for which any Vpu-mutant was significantly different from wild type. by Charlotte A. Stoneham (10819125)

Pair-wise comparison of the proximity-ome of wild type Vpu relative to the transmembrane domain mutant AAA/F. by Charlotte A. Stoneham (10819125)

IC₅₀ values of REJO SP mutants vs. WT by MAbs targeting V2i, V3, V2q, and the CD4bs and by CD-IgG2. by Chitra Upadhyay (817121)

Table 5_Quercetin exhibits multi-target anti-allergic effects in animal models: a systematic review and meta-analysis of preclinical studies.docx by Zeyi Lv (19344178)

“…Review Manager 5.4 software was used for analysis, and standardized mean differences (SMD) and 95% confidence intervals (CI) were calculated under a random-effects model.…”

Random forest identified stop codon identity, P-site amino acid identity, and 3’-UTR length as factors critical in readthrough efficiency prediction. by Kotchaphorn Mangkalaphiban (9767180)

“…<p><b>A.</b> Performance metric for random forest regression displaying average Normalized Root Mean Squared Error (NRMSE) ± standard deviation across 5-fold cross-validation. …”

Juxtanuclear endosomal distortion in cells expressing Vpu-S52,56N-APEX2. by Charlotte A. Stoneham (10819125)

Vpu-APEX2 fusion protein design and activity. by Charlotte A. Stoneham (10819125)

Astrocyte toxin attenuates the repeated 20-min photostimulation-induced cognitive impairment and neuroinflammation. by Jae-Hong Kim (124622)

Longitudinal associations between baseline CVR and 2 years changes in BDI-II score in participants with a BDI-II score <18 in the PREDIMED-PLUS trial at baseline. by Sandra Martín-Peláez (11353470)

Association between cardiovascular risk and a) depressive status (BDI-II ≥18) and b) BDI-II score, in the PREDIMED-PLUS trial, stratified by CVR factors, at baseline. by Sandra Martín-Peláez (11353470)